Our recent proteogenomic characterization of 105 human breast cancers linked 5q-loss to elevated EGFR expression and identified overexpression of phosphorylated kinases including CDK12, PAK1 and ARAF as potential biological drivers14. This evidence concerns the gene EGFR and breast carcinoma.